Information:
Error:
ID
41140
Description
Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation; ODM derived from: https://clinicaltrials.gov/show/NCT02125071
Link
https://clinicaltrials.gov/show/NCT02125071
Keywords
Versions (1)
- 6/30/20 6/30/20 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
June 30, 2020
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Liver Cirrhosis NCT02125071
Eligibility Liver Cirrhosis NCT02125071
- StudyEvent: Eligibility
Similar models
Eligibility Liver Cirrhosis NCT02125071
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Age
Item
male or female ≤18 years old
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
patients who understand the informed consent form and signed the form voluntarily
boolean
C0021430 (UMLS CUI [1])
Transplantation of liver Due to Hepatitis B | Prophylactic treatment Hepatitis B Relapse | Status post Transplantation of liver
Item
patients who underwent liver transplantation due to hbv related disease and will be treated for prevention of hepatitis b relapse after liver transplantation
boolean
C0023911 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0019163 (UMLS CUI [1,3])
C0199176 (UMLS CUI [2,1])
C0019163 (UMLS CUI [2,2])
C0035020 (UMLS CUI [2,3])
C0231290 (UMLS CUI [3,1])
C0023911 (UMLS CUI [3,2])
C0678226 (UMLS CUI [1,2])
C0019163 (UMLS CUI [1,3])
C0199176 (UMLS CUI [2,1])
C0019163 (UMLS CUI [2,2])
C0035020 (UMLS CUI [2,3])
C0231290 (UMLS CUI [3,1])
C0023911 (UMLS CUI [3,2])
Recipient Organ multiple | Surgical Replantation
Item
multi-organ recipient or reimplantation
boolean
C1709854 (UMLS CUI [1,1])
C0178784 (UMLS CUI [1,2])
C0439064 (UMLS CUI [1,3])
C0035139 (UMLS CUI [2])
C0178784 (UMLS CUI [1,2])
C0439064 (UMLS CUI [1,3])
C0035139 (UMLS CUI [2])
Immunoglobulin A deficiency
Item
iga deficiency
boolean
C0162538 (UMLS CUI [1])
Kidney Disease Serious
Item
serious nephropathy
boolean
C0022658 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,2])
Cardiovascular system Failure Serious
Item
serious cardiovascular system failure within 6 months
boolean
C0007226 (UMLS CUI [1,1])
C0231174 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0231174 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
Anemia Ischemic | Anemia, Hemolytic
Item
ischemic or hemolytic anemia
boolean
C0002871 (UMLS CUI [1,1])
C0475224 (UMLS CUI [1,2])
C0002878 (UMLS CUI [2])
C0475224 (UMLS CUI [1,2])
C0002878 (UMLS CUI [2])
Immunosuppression | Immunodeficiency
Item
condition of immunosuppression and immunodeficiency
boolean
C4048329 (UMLS CUI [1])
C0021051 (UMLS CUI [2])
C0021051 (UMLS CUI [2])
Hypersensitivity Blood product
Item
hypersensitivity or allergic to blood products
boolean
C0020517 (UMLS CUI [1,1])
C0456388 (UMLS CUI [1,2])
C0456388 (UMLS CUI [1,2])
HIV Seropositivity | Hepatitis C Virus Positive
Item
hiv or hcv positive
boolean
C0019699 (UMLS CUI [1])
C4330254 (UMLS CUI [2])
C4330254 (UMLS CUI [2])
Study Subject Participation Status | Clinical Trial
Item
participation to other clinical trial within 3 months
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
C0008976 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnancy or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Study Subject Participation Status Inappropriate
Item
those who the investigator determines inappropriate to participate
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,2])